Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2009 07:17 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Enters Into Second Exclusive Option to License Agreement for Antimicrobial Medical Device

DENVER, May 11, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered into an...
May 04, 2009 07:12 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Achieves 200 Days of Antimicrobial Efficacy On Treated Silicone Medical Device

DENVER, May 04, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a medical device company focused on infectious disease and dermatology, today announced that preclinical testing...
April 29, 2009 07:12 ET | Source: Ceragenix Pharmaceuticals

Ceragenix and MAST BioSurgery Enter Into Joint Development Agreement for New Antimicrobial Surgical Products

DENVER, Apr 29, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered into a...
February 25, 2009 07:13 ET | Source: Ceragenix Pharmaceuticals

Ceragenix and Pediapharm Enter Into Distribution and Supply Agreement for EpiCeram(R)

DENVER and MONTREAL, Feb 25, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has...
February 23, 2009 07:12 ET | Source: Ceragenix Pharmaceuticals

Japanese Researchers Find CSA-13 May be Useful for Prevention and Treatment of Dental Caries and Periodontal Disease

DENVER, Feb 23, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a medical device company focused on infectious disease and dermatology, today announced that in vitro research...
February 03, 2009 07:15 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Achieves 120 Days of Antimicrobial Efficacy on Treated Silicone Medical Device

DENVER, Feb 03, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a medical device company focused on infectious disease and dermatology, today announced that preclinical testing...
October 14, 2008 08:20 ET | Source: Ceragenix Pharmaceuticals

Promius Pharma, LLC Launches EpiCeram(R) Skin Barrier Emulsion

DENVER, Oct 14, 2008 -- Ceragenix Pharmaceuticals, Inc., (OTCBB:CGXP) today announced that Promius Pharma, LLC, a wholly owned subsidiary of Dr. Reddy's Laboratories (NYSE:RDY) ("DRL") launched its...
September 22, 2008 12:25 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Satisfies Conditions for $1 Million Milestone Payment under Supply and Distribution Agreement

DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a medical device company focused on infectious disease and dermatology, today announced that it had satisfied the conditions...
May 20, 2008 08:26 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Announces Results of a Comparison Study of the Safety and Efficacy of EpiCeram(R) Cream for the Treatment of Mild to Moderate Pediatric Atopic Dermatitis

DENVER, May 20, 2008 -- Ceragenix Pharmaceuticals Inc. (OTCBB:CGXP) today announced positive results from its investigator-blinded study comparing the safety and efficacy of EpiCeram(R) Skin Barrier...
April 29, 2008 08:17 ET | Source: Ceragenix Pharmaceuticals

CeraShield(TM) Coated Urinary Catheters Provide Superior Protection Against Bacterial Colonization Compared to Leading Brands in Preclinical Testing

DENVER, Apr 29, 2008 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today presented...